Information  X 
Enter a valid email address
  Print      Mail a friend       More announcements

Monday 23 November, 2015

BlackRock Group

Form 8.3 - Pfizer, Inc.

RNS Number : 6623G
BlackRock Group
23 November 2015
 



Ap19

 

 

FORM 8.3

 

IRISH TAKEOVER PANEL

 

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

 

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

 

1.       KEY INFORMATION

 

Name of person dealing (Note 1)

BlackRock, Inc.

Company dealt in

Pfizer, Inc.

Class of relevant security to which the dealings being disclosed relate (Note 2)

US$0.05 common stock

Date of dealing

20 November 2015

 

2.         INTERESTS AND SHORT POSITIONS

 

(a)        Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)


Long

Short


Number


(%)

Number


(%)

(1) Relevant securities

395,225,902       (6.40%)

516,078        (0.00%)

(2) Derivatives (other than options)

    1,363,337      (0.02%)

11,021          (0.00%)

(3) Options and agreements to purchase/sell

20,000,000        (0.32%)

21,200,800      (0.34%)

Total

416,589,239       (6.74%)

21,727,899       (0.35%)

 

(b)        Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

Class of relevant security:

Long

Short


Number


(%)

Number


(%)

(1) Relevant securities



 

(2) Derivatives (other than options)



 

(3) Options and agreements to purchase/sell



Total




Ap20

 

 

1.       DEALINGS (Note 4)

 

(a)      Purchases and sales

 

 

 

Purchase/sale

 

Number of relevant securities

 

Price per unit (Note 5)

Purchase

36,339

USD 32.1800

Purchase

650

USD 32.2635

Purchase

2,290

USD 32.5150

Purchase

8,195

USD 32.5214

Sale

98,588

USD 32.1800

Sale

16,400

USD 32.4699

   

Please note: there was also a Transfer In of 97,190 Shares.

 

(b)      Derivatives transactions (other than options transactions)

 

Product name,

e.g. CFD

Nature of transaction

(Note 6)

Number of relevant securities

(Note 7)

Price per unit

(Note 5)

CFD

Increasing Long

1,301

USD 32.1949

CFD

Increasing Long

4,082

USD 32.3130

CFD

Increasing Long

1,692

USD 32.3141

   

 

 

 

 

 

 

 

(c)      Options transactions in respect of existing relevant securities

 

 

(i)       Writing, selling, purchasing or varying

 

Product name,

e.g. call option

Writing, selling, purchasing, varying etc.

Number of securities to which the option relates (Note 7)

Exercise price

Type, e.g. American, European etc.

Expiry date

Option money paid/received per unit (Note 5)

Call Option

Written

225,000

USD

34.0000

American

15/01/2016

USD

0.6556

 

 

(ii)      Exercising

 

Product name,

e.g. call option

Number of securities

Exercise price per unit (Note 5)




 

(d)      Other dealings (including transactions in respect of new securities) (Note 4)

 

Nature of transaction

(Note 8)

Details

Price per unit

(if applicable) (Note 5)

Return of stock on loan

84,000

N/A

   


Ap21

 

2.       OTHER INFORMATION

 

Agreements, arrangements or understandings relating to options or derivatives

 

 

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any 

relevant securities to which any derivative referred to on this form is referenced. If none, 

this should be stated.

 

 

 

None

 

 

 

Is a Supplemental Form 8 attached? (Note 9)                                    YES

 

Date of disclosure

23 November 2015

Contact name

Tim Dudley

Telephone number

+44 20 7743 1540

If a connected EFM, name of offeree/offeror with which connected


If a connected EFM, state nature of connection (Note 10)


 



 

Ap23

 

 

SUPPLEMENTAL FORM 8

 

IRISH TAKEOVER PANEL

 

DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

 

DETAILS OF OPEN POSITIONS

 

(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or Form 8.3, as appropriate)

 

OPEN POSITIONS (Note 1)

 

Product name,

e.g. call option

Written, or purchased

Number of relevant securities to which the option or derivative relates

Exercise price (Note 2)

Type, e.g. American, European etc.

Expiry date

Call Option

Written

110,200

USD 34.0000

American

04/12/2015

Call Option

Written

186,000

USD 34.5000

American

04/12/2015

Call Option

Purchased

20,000,000

USD 34.5000

American

04/12/2015

Call Option

Written

299,400

USD 35.0000

American

04/12/2015

Call Option

Written

270,000

USD 34.0000

American

18/12/2015

Call Option

Written

110,200

USD 35.0000

American

18/12/2015

Call Option

Written

20,000,000

USD 37.5000

American

15/01/2016

Call Option

Written

225,000

USD 34.0000

American

15/01/2016

 

Notes

 

1.         Where there are open option positions or open derivative positions (except for CFDs), full details should be given. Full details of any existing agreements to purchase or to sell must also be given on this form.

 

2.          For all prices and other monetary amounts, the currency must be stated.

 

For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ISEPGGMGGUPAGAW

a d v e r t i s e m e n t